The results of this study showed that the lowest MIC value of the ethanolic extract was 6.25 ppm, which inhibited two stains, while its highest MIC value was 25 ppm, inhibiting three bacterial strains. The highest MBC value of the ethanolic extract was 50 ppm, which completely eliminated three strains.
The lowest MIC value of the ethyl acetate extract against P. aeruginosa was 12.5 ppm, inhibiting five bacterial strains and the highest MIC value was 50 ppm, where one strain was inhibited. The highest MBC value of the ethyl acetate extract was 100 ppm, which completely eliminated one strain.
In a study by Saeedi et al., the results showed that the MIC of
Myrtus communis L. extract was 5 mg/mL, while the minimum trace concentration (MTC) of the extract was 10 mg/mL (
9).
The results reported by Salvagnini et al. revealed that the ethanolic extract of
M. communis had antimicrobial activity against
Staphylococcus aureus (
10). The methanolic and ethanolic extracts of leaves of
Myrtus communis had antimicrobial activity against
Listeria monocytogenes,
P. aeruginosa and
S. aureus, and the inhibition zone diameters of the ethanolic extract for these bacteria were 30, 23 and 37 mm, respectively, and the MTC for
S. aureus was less than 0.75 mg/mL (
11). In a previous study in Iran, the positive effect of the alcoholic extract of
Myrtus communis on
Escherichia coli was reported. Also, according to Ghasemi et al., methanolic extract of
M. communis showed a significant effect on intrusive propagation activity, but the MBC for
E. coli was higher than 10 mg/mL (
12,
13).
In a study of Bouzabata, the results showed that compositions of
M. communis were α-pinene, linalool, and linalyl acetate (
14).
Ben Hsouna et al. evaluated the in vitro antibacterial and antifungal properties of the
M. communis essential oil. They showed that of the inhibition zones and MICs of the plant’s essential oil were within the ranges of 16 - 28 mm and 0.078 - 2.5 mg/mL, respectively (
15).
Barac explored the antifungal activity of
M. communis essential oil against
Malassezia spp. isolated from the skin of patients with pityriasis versicolor. The results showed the antimicrobial activity of
M. communis essential oil against of
Malassezia (
16).
In a study by Anwar,
M. communis essential oil was assessed for its antimicrobial activity, the results demonstrated the antibacterial and antifungal activities of this essential oil against
Bacillus subtilis,
S. aureus and
Candida albicans. The oil moderately reduced the radical diphenylpicryl-hydrazyl (IC
50 = 4.2 μL/mL or 4.1 mg/mL) (
17).
Aleksic determined antimicrobial activity of
M. communis L. essential oil against multidrug resistant (MDR)
A. baumannii isolated from infected wound (
18).
The study of Pirbalouti revealed that the essential oil of
M. communis had strong antibacterial activity against
E. rhusiopathiae. The inhibition zones and MIC values for the bacteria that were sensitive to
M. communis essential oil were within the ranges of 14.7 - 27.0 mm and 0.031 - 0.25 mg/mL, respectively (
19).
In the study P. aeruginosa were resistant to all antibiotics at the following rates: AZM (25%), Am (12.5%), GM (0%), AMC (12.5%), CZ (12.5%), and AN (12.5%).
Mardaneh et al. (
20) conducted a study on 111
P. aeruginosa strains isolated from hospitalized patients. Clinical specimens were cultured on microbiological media. Subsequently, drug susceptibility test was performed using the disc diffusion method according to CLSI recommendations. Their results indicated that most
P. aeruginosa strains were from wound specimens (48.6%). In antimicrobial susceptibility testing, colistin exhibited the greatest anti-
Pseudomonas activity (78.3%). Isolates demonstrated resistance to beta-lactam antimicrobials such as antipseudomonal penicillins, including piperacillin and carbenicillin.
Mohageri (
21) examined antibiotic susceptibility and resistance of
Pseudomonas aeruginosa strains in Kermanshah, Iran. The results showed that resistance was 38% to amikacin, 72% to carbonyl, 50% to ceftazidime, 38% to ciprofloxacin, 52% to gentamicin, 100% to imipenem, 98% to mesosylin, 90% to ticarsillin, and 46% to tobramycin.
Ruiz-Roldán et al. reported low antimicrobial resistance levels as follows: Ceftazidime (8%), cefepime (7%), aztreonam (7%), gentamicin (3%), ciprofloxacin (1%), and imipenem (1%). Four MDR strains were found in that study (
22).
Igbalajobi et al. investigated the prevalence of acquired MDR of
P. aeruginosa among clinical samples obtained from patients attending Ekiti State University Teaching Hospital, Ado Ekiti, Ekiti State, Nigeria. The results show that 80.95% of the isolates were resistant to ceftriaxone and ceftizoxime, 76.2% to augmentin, 73.8% to ceftazidime, 71.4% to nitrofurantoin, 47.6% to ofloxacin, 45.23% to gentamicin. The lowest resistance was to ciprofloxacin (42.86%) (
23).
5.1. Conclusions
The results showed that the antimicrobial effects of the extracts were enhanced by increasing concentration.